A股申购 | 爱舍伦(920050.BJ)开启申购 长期专注于医疗健康事业

Core Viewpoint - Aishalon (920050.BJ) has initiated its subscription with an issue price of 15.98 CNY per share and a price-to-earnings ratio of 14.99 times, focusing on the medical health sector, particularly in disposable medical consumables for rehabilitation and medical protection [1] Group 1: Company Overview - Aishalon specializes in the research, production, and sales of disposable medical consumables, primarily in rehabilitation care and medical protection [1] - The company operates through ODM/OEM models, providing products for internationally recognized medical device brands [1] - Aishalon's product range includes rehabilitation care products and surgical infection control products, expanding into disinfection, home protection, and emergency protection [1] Group 2: Financial Performance - The company reported revenues of approximately 574 million CNY, 575 million CNY, 692 million CNY, and 438 million CNY for the years 2022, 2023, 2024, and the first half of 2025, respectively [2] - Net profits for the same periods were approximately 62.8 million CNY, 66.9 million CNY, 80.6 million CNY, and 49.4 million CNY [2] - The total assets as of June 30, 2025, were approximately 1.2 billion CNY, with total equity of about 795 million CNY [3] Group 3: Customer Concentration - The top five customers accounted for 81.99%, 86.27%, 86.27%, and 88.40% of total sales revenue over the reporting periods, indicating high customer concentration [2] - The largest customer, Medline Group, represented 71.51%, 73.08%, 71.00%, and 77.73% of sales, significantly impacting the company's financial performance [2]